Acute pharmacological modulation of mGluR8 reduces measures of anxiety

Robert Duvoisin, Tim Pfankuch, Julie M. Wilson, Julie Grabell, Vijay Chhajlani, Dean G. Brown, Edwin Johnson, Jacob Raber

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Metabotropic glutamate receptors (mGluRs), which are coupled to second messenger pathways via G proteins, modulate glutamatergic and GABAergic neurotransmission. Because of their role in modulating neurotransmission, mGluRs are attractive therapeutic targets for anxiety disorders. Previously we showed that mGluR8-/- male mice showed higher measures of anxiety in the open field and elevated plus maze than age-matched wild-type mice. In this study, we assessed the potential effects of acute pharmacological modulation of mGluR8 on measures of avoidable and unavoidable anxiety. In addition to wild-type mice, we also tested apolipoprotein E-deficient (Apoe-/-) mice, as these mice show increased levels of anxiety-like behaviors and therefore might show an altered sensitivity to mGluR8 stimulation. mGluR8 stimulation with the specific agonist DCPG, or modulation with AZ12216052, a new, positive allosteric modulator of mGluR8 reduced measures of anxiety in both wild-type mice. The effects of mGluR8 positive allosteric modulators, which only affect neurotransmission in the presence of extracellular glutamate, seem particularly promising for patients with anxiety disorders showing benzodiazepine insensitivity.

Original languageEnglish (US)
Pages (from-to)168-173
Number of pages6
JournalBehavioural Brain Research
Volume212
Issue number2
DOIs
StatePublished - Oct 2010

Fingerprint

Anxiety
Pharmacology
Synaptic Transmission
Metabotropic Glutamate Receptors
Anxiety Disorders
Second Messenger Systems
Apolipoproteins E
Benzodiazepines
GTP-Binding Proteins
metabotropic glutamate receptor 8
Glutamic Acid
Therapeutics

Keywords

  • Allosteric modulator
  • Behavior
  • Group-III mGluR
  • Metabotropic

ASJC Scopus subject areas

  • Behavioral Neuroscience
  • Medicine(all)

Cite this

Acute pharmacological modulation of mGluR8 reduces measures of anxiety. / Duvoisin, Robert; Pfankuch, Tim; Wilson, Julie M.; Grabell, Julie; Chhajlani, Vijay; Brown, Dean G.; Johnson, Edwin; Raber, Jacob.

In: Behavioural Brain Research, Vol. 212, No. 2, 10.2010, p. 168-173.

Research output: Contribution to journalArticle

Duvoisin, R, Pfankuch, T, Wilson, JM, Grabell, J, Chhajlani, V, Brown, DG, Johnson, E & Raber, J 2010, 'Acute pharmacological modulation of mGluR8 reduces measures of anxiety', Behavioural Brain Research, vol. 212, no. 2, pp. 168-173. https://doi.org/10.1016/j.bbr.2010.04.006
Duvoisin, Robert ; Pfankuch, Tim ; Wilson, Julie M. ; Grabell, Julie ; Chhajlani, Vijay ; Brown, Dean G. ; Johnson, Edwin ; Raber, Jacob. / Acute pharmacological modulation of mGluR8 reduces measures of anxiety. In: Behavioural Brain Research. 2010 ; Vol. 212, No. 2. pp. 168-173.
@article{0c849680b7b7459a92b589e5671bf533,
title = "Acute pharmacological modulation of mGluR8 reduces measures of anxiety",
abstract = "Metabotropic glutamate receptors (mGluRs), which are coupled to second messenger pathways via G proteins, modulate glutamatergic and GABAergic neurotransmission. Because of their role in modulating neurotransmission, mGluRs are attractive therapeutic targets for anxiety disorders. Previously we showed that mGluR8-/- male mice showed higher measures of anxiety in the open field and elevated plus maze than age-matched wild-type mice. In this study, we assessed the potential effects of acute pharmacological modulation of mGluR8 on measures of avoidable and unavoidable anxiety. In addition to wild-type mice, we also tested apolipoprotein E-deficient (Apoe-/-) mice, as these mice show increased levels of anxiety-like behaviors and therefore might show an altered sensitivity to mGluR8 stimulation. mGluR8 stimulation with the specific agonist DCPG, or modulation with AZ12216052, a new, positive allosteric modulator of mGluR8 reduced measures of anxiety in both wild-type mice. The effects of mGluR8 positive allosteric modulators, which only affect neurotransmission in the presence of extracellular glutamate, seem particularly promising for patients with anxiety disorders showing benzodiazepine insensitivity.",
keywords = "Allosteric modulator, Behavior, Group-III mGluR, Metabotropic",
author = "Robert Duvoisin and Tim Pfankuch and Wilson, {Julie M.} and Julie Grabell and Vijay Chhajlani and Brown, {Dean G.} and Edwin Johnson and Jacob Raber",
year = "2010",
month = "10",
doi = "10.1016/j.bbr.2010.04.006",
language = "English (US)",
volume = "212",
pages = "168--173",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Acute pharmacological modulation of mGluR8 reduces measures of anxiety

AU - Duvoisin, Robert

AU - Pfankuch, Tim

AU - Wilson, Julie M.

AU - Grabell, Julie

AU - Chhajlani, Vijay

AU - Brown, Dean G.

AU - Johnson, Edwin

AU - Raber, Jacob

PY - 2010/10

Y1 - 2010/10

N2 - Metabotropic glutamate receptors (mGluRs), which are coupled to second messenger pathways via G proteins, modulate glutamatergic and GABAergic neurotransmission. Because of their role in modulating neurotransmission, mGluRs are attractive therapeutic targets for anxiety disorders. Previously we showed that mGluR8-/- male mice showed higher measures of anxiety in the open field and elevated plus maze than age-matched wild-type mice. In this study, we assessed the potential effects of acute pharmacological modulation of mGluR8 on measures of avoidable and unavoidable anxiety. In addition to wild-type mice, we also tested apolipoprotein E-deficient (Apoe-/-) mice, as these mice show increased levels of anxiety-like behaviors and therefore might show an altered sensitivity to mGluR8 stimulation. mGluR8 stimulation with the specific agonist DCPG, or modulation with AZ12216052, a new, positive allosteric modulator of mGluR8 reduced measures of anxiety in both wild-type mice. The effects of mGluR8 positive allosteric modulators, which only affect neurotransmission in the presence of extracellular glutamate, seem particularly promising for patients with anxiety disorders showing benzodiazepine insensitivity.

AB - Metabotropic glutamate receptors (mGluRs), which are coupled to second messenger pathways via G proteins, modulate glutamatergic and GABAergic neurotransmission. Because of their role in modulating neurotransmission, mGluRs are attractive therapeutic targets for anxiety disorders. Previously we showed that mGluR8-/- male mice showed higher measures of anxiety in the open field and elevated plus maze than age-matched wild-type mice. In this study, we assessed the potential effects of acute pharmacological modulation of mGluR8 on measures of avoidable and unavoidable anxiety. In addition to wild-type mice, we also tested apolipoprotein E-deficient (Apoe-/-) mice, as these mice show increased levels of anxiety-like behaviors and therefore might show an altered sensitivity to mGluR8 stimulation. mGluR8 stimulation with the specific agonist DCPG, or modulation with AZ12216052, a new, positive allosteric modulator of mGluR8 reduced measures of anxiety in both wild-type mice. The effects of mGluR8 positive allosteric modulators, which only affect neurotransmission in the presence of extracellular glutamate, seem particularly promising for patients with anxiety disorders showing benzodiazepine insensitivity.

KW - Allosteric modulator

KW - Behavior

KW - Group-III mGluR

KW - Metabotropic

UR - http://www.scopus.com/inward/record.url?scp=77953020355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953020355&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2010.04.006

DO - 10.1016/j.bbr.2010.04.006

M3 - Article

C2 - 20385173

AN - SCOPUS:77953020355

VL - 212

SP - 168

EP - 173

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

IS - 2

ER -